Suscribirse

Periacetabular osteotomy vs. total hip arthroplasty in young active patients with dysplastic hip: Systematic review and meta-analysis - 03/12/20

Doi : 10.1016/j.otsr.2020.08.012 
Chul-Ho Kim a, Ji Wan Kim b,
a Department of Orthopedic Surgery, Gachon University Gil Medical Center, Incheon, Republic of Korea 
b Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea 

Corresponding author at: Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea.Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine88, Olympic-ro 43-gil, Songpa-guSeoulRepublic of Korea

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

In young active patients with hip dysplasia, choosing between periacetabular osteotomy (PAO) and total hip arthroplasty (THA) is challenging.

Materials and methods

We systematically searched Medline, Embase, and Cochrane Library for studies published until October 10, 2019, comparing PAO and THA in patients with dysplastic hip. We compared postoperative complications’ incidences, end-stage revisions, and clinical scores.

Results

Five studies with 431 hips (PAO: 235; THA: 196) were included. The incidence of overall and major complications was not different between groups (PAO: OR 2.14; 95% CI, 0.58–7.96; p=0.26; follow-up, 4–7.8 years; THA: OR 2.56; 95% CI, 0.60–10.98; p=0.21; follow-up, 4–7.8 years). There was also no difference in end-stage revision (OR 0.95; 95% CI, 0.33–2.79; p=0.93; follow-up, 4–7.8 years). The standard mean of Western Ontario McMasters Universities (WOMAC) pain score was higher in the THA than in the PAO group (standardized mean difference [SMD] −0.57; 95% CI, −0.93–−0.21; p=0.002; follow-up, 4–5.5 years); however, the WOMAC functional score did not differ significantly between groups (SMD −0.16; 95% CI, −1.29–0.97; p=0.78; follow-up, 4–5.5 years). The standard mean UCLA activity index was higher in the PAO than in the THA group (SMD 0.28; 95% CI, 0.02–0.53; p=0.03; follow-up, 5.9–7.3 years).

Conclusions

The incidence of postoperative complications and revision surgery was not different between THA and PAO groups. However, postoperative pain was less in the THA group and the activity score was higher in the PAO group in the follow-up periods.

Level of evidence

III; meta-analysis.

El texto completo de este artículo está disponible en PDF.

Keywords : Periacetabular osteotomy, Total hip arthroplasty, Hip dysplasia, Acetabular dysplasia, Symptomatic


Esquema


© 2020  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 106 - N° 8

P. 1545-1551 - décembre 2020 Regresar al número
Artículo precedente Artículo precedente
  • Does hip or knee joint replacement decrease chances to complete an ultra-trail race? Study in participants at the Ultra-Trail du Mont Blanc®
  • Michaël Rochoy, Julien Six, Jonathan Favre, Nicolas Lagrange, Jean-Marc Lefebvre, Jean-Charles Rollier, Julien Girard
| Artículo siguiente Artículo siguiente
  • Does prior core decompression have detrimental effect on subsequent total hip arthroplasty for osteonecrosis of the femoral head: A systematic review and meta-analysis
  • Wang Deng, Zhaolun Wang, Yixin Zhou, Hongyi Shao, Dejin Yang, Hua Li

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.